HIMS & HERS HEALTH, INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.0M | $526.9M | $271.9M | $148.8M | $82.6M |
| Cost of Revenue | $614.3M | $303.4M | $157.1M | $118.2M | $67.4M | $39.3M | $38.0M |
| Gross Profit | $1.73B | $1.17B | $714.9M | $408.7M | $204.5M | $109.5M | $44.6M |
| Gross Margin | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% | 73.6% | 54.0% |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | $272.7M | $167.8M | $129.9M | $98.2M | $183.6M | $65.6M | $55.9M |
| Operating Income | $105.6M | $61.9M | $-29.5M | $-68.7M | $-115.0M | $-15.1M | $-74.4M |
| Operating Margin | 4.5% | 4.2% | -3.4% | -13.0% | -42.3% | -10.2% | -90.1% |
| Interest Expense | — | — | — | — | $0 | $10.0K | $369.0K |
| Pretax Income | $123.9M | $71.7M | $-21.6M | $-65.7M | $-110.8M | $-18.0M | $-72.0M |
| Income Tax Expense | $-4.4M | $-54.3M | $2.0M | $-31.0K | $-3.1M | $127.0K | $90.0K |
| Net Income | $128.4M | $126.0M | $-23.5M | $-65.7M | $-107.7M | $-18.1M | $-72.1M |
| Net Margin | 5.5% | 8.5% | -2.7% | -12.5% | -39.6% | -12.2% | -87.3% |
| EPS (Basic) | $0.57 | $0.58 | $-0.11 | $-0.32 | $-0.58 | $-0.10 | $-0.41 |
| EPS (Diluted) | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 | $-0.10 | $-0.41 |
| Shares Outstanding (Basic) | 225.0M | 215.9M | 209.3M | 204.5M | 186.8M | 176.8M | 173.8M |
| Shares Outstanding (Diluted) | 258.2M | 236.8M | 209.3M | 204.5M | 186.8M | 176.8M | 173.8M |
| Dividends Per Share | — | — | — | — | — | — | — |